FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4239013637> ?p ?o ?g. }

• W4239013637 abstract "Excessively heavy menstrual bleeding (HMB) or menorrhagia is an important cause of ill health in women. Eighty per cent of women treated for HMB have no anatomical pathology and so medical therapy, with the avoidance of possibly unnecessary surgery, is an attractive alternative. Of the wide variety of medications used to reduce heavy menstrual bleeding, oral progestogens are the most commonly prescribed in many western countries, although there is little objective evidence to support their use, especially in women with ovulatory menstruation. This review assesses the effectiveness of 2 different regimens of oral progestogens in reducing ovulatory HMB.The primary objective of this review is to investigate the effectiveness of oral progestogen therapy taken either during the luteal phase or for a longer course of 21 days in achieving a reduction in menstrual blood loss in women of reproductive years with heavy menstrual bleeding (HMB).Electronic searches for relevant randomised controlled trials of the Cochrane Menstrual Disorders and Subfertility Group Register of Trials, MEDLINE, EMBASE, PsychLIT, Current Contents, Biological Abstracts, Social Sciences Index and CINAHL were performed. Attempts were also made to identify trials from citation lists of review articles. In most cases, the first author of each included trial was contacted.The inclusion criteria were randomised comparisons of oral progestogen therapy versus placebo or other medical treatments in women of reproductive years with regular heavy periods measured either objectively or subjectively and with no pathological or iatrogenic causes for their heavy menstrual blood loss.Seven randomised controlled trials (RCTs) were identified that fulfilled the inclusion criteria for this review. The reviewers extracted the data independently and odds ratios for dichotomous outcomes and weighted mean differences for continuous outcomes were estimated from the data.No RCTs comparing progestogen treatment with placebo were identified. Comparisons between oral progestogens and other medical therapies were assessed separately according to dosage regimen, progestogens given during the luteal phase of the menstrual cycle and progestogens given for 21 days between day 5 and 26. Progestogen therapy during the luteal phase was significantly less effective at reducing menstrual blood loss when compared with tranexamic acid, danazol and the progesterone releasing intrauterine system (IUS) and there was also a strong non-significant trend in favour of nonsteroidal anti-inflammatory drugs (NSAIDs). Duration of menstruation was significantly longer with the progesterone IUS when compared with oral progestogen therapy but significantly shorter under danazol treatment. Compliance and acceptability of treatment where measured did not differ between treatments. Adverse events were significantly more likely under danazol when compared with progestogen treatment. Change in quality of life was not significantly different with progestogen and tranexamic acid therapy but there was a non-significant trend in favour of tranexamic acid for all three categories. Progestogen therapy administered from day 5 to 26 of the menstrual cycle was significantly less effective at reducing menstrual blood loss than the progestogen releasing intrauterine system (LNG IUS) although the reduction from baseline was significant for both groups. The odds of the menstrual period becoming normal (ie <80mls/cycle) were also less likely in patients treated with norethisterone (NET) (days 5 to 26) compared to patients treated with LNG IUS. A significantly higher proportion of NET patients found their treatment unacceptable compared to LNG IUS patients. However, the adverse events breast tenderness and intermenstrual bleeding were more likely in the patients with the IUS. (ABSTRACT TRUNCATED)" @default.
• W4239013637 created "2022-05-12" @default.
• W4239013637 creator A5009731454 @default.
• W4239013637 creator A5011375334 @default.
• W4239013637 creator A5071034818 @default.
• W4239013637 date "1998-10-26" @default.
• W4239013637 modified "2023-09-26" @default.
• W4239013637 title "Cyclical progestogens for heavy menstrual bleeding" @default.
• W4239013637 cites W1988697850 @default.
• W4239013637 cites W1989584403 @default.
• W4239013637 cites W2007749187 @default.
• W4239013637 cites W2012165536 @default.
• W4239013637 cites W2031785143 @default.
• W4239013637 cites W2038994407 @default.
• W4239013637 cites W2042374015 @default.
• W4239013637 cites W2068455631 @default.
• W4239013637 cites W2078756876 @default.
• W4239013637 cites W2085847265 @default.
• W4239013637 cites W2091692603 @default.
• W4239013637 cites W2096824429 @default.
• W4239013637 cites W2097047879 @default.
• W4239013637 cites W2108814154 @default.
• W4239013637 cites W4247840597 @default.
• W4239013637 doi "https://doi.org/10.1002/14651858.cd001016" @default.
• W4239013637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10796587" @default.
• W4239013637 hasPublicationYear "1998" @default.
• W4239013637 type Work @default.
• W4239013637 citedByCount "7" @default.
• W4239013637 countsByYear W42390136372013 @default.
• W4239013637 countsByYear W42390136372019 @default.
• W4239013637 crossrefType "reference-entry" @default.
• W4239013637 hasAuthorship W4239013637A5009731454 @default.
• W4239013637 hasAuthorship W4239013637A5011375334 @default.
• W4239013637 hasAuthorship W4239013637A5071034818 @default.
• W4239013637 hasConcept C126322002 @default.
• W4239013637 hasConcept C131872663 @default.
• W4239013637 hasConcept C141071460 @default.
• W4239013637 hasConcept C142724271 @default.
• W4239013637 hasConcept C168563851 @default.
• W4239013637 hasConcept C204787440 @default.
• W4239013637 hasConcept C27081682 @default.
• W4239013637 hasConcept C2776478404 @default.
• W4239013637 hasConcept C2777164284 @default.
• W4239013637 hasConcept C2779058012 @default.
• W4239013637 hasConcept C2779637338 @default.
• W4239013637 hasConcept C2779771394 @default.
• W4239013637 hasConcept C2780572241 @default.
• W4239013637 hasConcept C29456083 @default.
• W4239013637 hasConcept C2991743468 @default.
• W4239013637 hasConcept C2992922752 @default.
• W4239013637 hasConcept C535046627 @default.
• W4239013637 hasConcept C71315377 @default.
• W4239013637 hasConcept C71924100 @default.
• W4239013637 hasConceptScore W4239013637C126322002 @default.
• W4239013637 hasConceptScore W4239013637C131872663 @default.
• W4239013637 hasConceptScore W4239013637C141071460 @default.
• W4239013637 hasConceptScore W4239013637C142724271 @default.
• W4239013637 hasConceptScore W4239013637C168563851 @default.
• W4239013637 hasConceptScore W4239013637C204787440 @default.
• W4239013637 hasConceptScore W4239013637C27081682 @default.
• W4239013637 hasConceptScore W4239013637C2776478404 @default.
• W4239013637 hasConceptScore W4239013637C2777164284 @default.
• W4239013637 hasConceptScore W4239013637C2779058012 @default.
• W4239013637 hasConceptScore W4239013637C2779637338 @default.
• W4239013637 hasConceptScore W4239013637C2779771394 @default.
• W4239013637 hasConceptScore W4239013637C2780572241 @default.
• W4239013637 hasConceptScore W4239013637C29456083 @default.
• W4239013637 hasConceptScore W4239013637C2991743468 @default.
• W4239013637 hasConceptScore W4239013637C2992922752 @default.
• W4239013637 hasConceptScore W4239013637C535046627 @default.
• W4239013637 hasConceptScore W4239013637C71315377 @default.
• W4239013637 hasConceptScore W4239013637C71924100 @default.
• W4239013637 hasLocation W42390136371 @default.
• W4239013637 hasLocation W42390136372 @default.
• W4239013637 hasOpenAccess W4239013637 @default.
• W4239013637 hasPrimaryLocation W42390136371 @default.
• W4239013637 hasRelatedWork W2101146672 @default.
• W4239013637 hasRelatedWork W2120216515 @default.
• W4239013637 hasRelatedWork W2267236603 @default.
• W4239013637 hasRelatedWork W2321973160 @default.
• W4239013637 hasRelatedWork W2407073336 @default.
• W4239013637 hasRelatedWork W2883421150 @default.
• W4239013637 hasRelatedWork W2914717873 @default.
• W4239013637 hasRelatedWork W2979748849 @default.
• W4239013637 hasRelatedWork W3175036048 @default.
• W4239013637 hasRelatedWork W2182522524 @default.
• W4239013637 isParatext "false" @default.
• W4239013637 isRetracted "false" @default.
• W4239013637 workType "reference-entry" @default.